ANN ARBOR, Mich., USA - October 6, 2010 - Health Level Seven® (HL7®) International, the global authority on standards for interoperability of health information technology with members in 55 countries, today announced election results for its Board of Directors during the business meeting at the 24th Annual Plenary and Working Group Meeting. The 2010 recipients of the W. Edward Hammond, PhD, Volunteer of the Year Awards were also recognized at the event.
Incoming Chairman: Donald Mon, PhD, vice president - practice leadership, American Health Information Management Association, was selected by the membership to serve as the chair-elect in 2011 and as the chairman, 2012-2013.
HL7 Board Member Elections
Four members were elected or re-elected to the HL7 Board of Directors for the 2010-2011 term:
- Secretary - Jill Kaufman, PhD, director, personalized healthcare initiatives, College of American Pathologists
- Director - Keith Boone, lead interoperability systems designer, GE Healthcare Integrated IT Solutions
- Director - W. Edward Hammond, PhD, professor emeritus, Duke University
- Affiliate Director - Catherine Chronaki, HL7 Greece Board of Directors and senior software engineer, FORTH-Institute of Computer Science
HL7 Volunteers of the Year
HL7 honored seven members with the 14th annual W. Edward Hammond, PhD Volunteer of the Year Award. Established in 1997, the award is named after Dr. Ed Hammond, one of HL7's most active volunteers and a founding member as well as past Board chair. The award recognizes individuals who have made significant contributions to HL7's success. The 2010 recipients include:
- Hugh Glover and Julie James, HL7 UK
- Stan Huff, MD, chief medical informatics officer, Intermountain Healthcare
- Charlie Mead, MD, MSc, CTO, 3rd Millennium, Inc.
- Mark Shafarman, principal, Shafarman Consulting
- D. Mead Walker, Health Data and Interoperability, Inc.
- Pat Van Dyke, Delta Dental Plans Association
About the Volunteers:
Hugh Glover and Julie James have been involved with HL7 since 2001. They are receiving the award jointly as they are partners both personally and professionally. They have both actively contributed to HL7 for many years and have held leadership positions in the Pharmacy Work Group such as a co-chair or facilitator. Their backgrounds-James as a pharmacist and Glover's expertise in data modeling-complement each other and have brought valuable insight to HL7. Both have been involved with Version 3 development since its inception. James is also active in the Patient Safety Work Group. She currently serves as a Vocabulary Facilitator for medication and pharmacy. Glover currently serves as the Pharmacy Work Group representative on the Common Product Model project. He also serves as a Modeling and Methodology Facilitator for medication and as a Vocabulary Facilitator for CMET.
Stan Huff, MD is a long-time member of HL7 and currently sits on the HL7 Board of Directors. An international expert on vocabulary, he was one of the first co-chairs elected to lead HL7's Vocabulary Work Group, a position he held for nearly a decade. He was also one of the early co-chairs for HL7's Templates Work Group. Additionally, Huff has been elected to the HL7 Board of Directors twice, serving as chair from 2000 - 2001. Actively involved in the development of Version 3, he has served as Vocabulary Facilitator for the Vocabulary and Orders and Observations Work Groups. In 2008, Huff was named to the HL7 Roadmap Committee, and in 2009 he was elected by the Board of Directors to serve as the U.S. representative to the HL7 International Council.
Charlie Mead, MD has been a member of HL7 since 1995. For many years, he co-chaired the Patient Care Work Group and later became co-chair of Personnel Management. Mead was a member of the HL7 International Board of Directors for two terms, serving one of them as Treasurer. An avid participant in the development of Version 3, he was among the initial Modeling and Methodology facilitators and has spearheaded efforts over the years to improve the accessibility and readability of Version 3.
A member of the CDISC Board of Directors, Mead has encouraged and nurtured collaborations between CDISC and HL7, and has been an active participant in the Regulated Clinical Research Information Management (RCRIM) Work Group. With support from HL7 RCRIM, CDISC, and FDA, he founded the project that developed the model we now know as the Biomedical Research Integrated Domain Group (BRIDG) model. Mead currently serves as chair of the Architectural review Board (ArB), and is instrumental in driving the development of the Services Aware Interoperability Framework, known as SAIF.
Mark Shafarman has been a member of HL7 since 1992. He has served HL7 in almost every capacity including co-chair of the Control Query Work Group for many years, co-chair of the Templates Work Group (a position that he holds today), and as co-chair of the initial Affiliates' Council. Shafarman also held the position of the Chair of HL7 from 2004 - 2005, and served on the HL7 Board of Directors, the Technical Steering Committee, and the ArB for a number of years. He was integral in the development of the original HL7 Version 2 certification exam and currently serves as an HL7 Ambassador.
In addition, HL7's current working relationship with the European Committee for Standardization (CEN) was forged under Sharfarman's leadership, and he has served as HL7's liaison to that organization for a number of years.
D. Mead Walker has been a member of HL7 since 1993. Shortly after joining, he was elected co-chair of the Quality Assurance/Data Modeling Committee, a precursor to today's Modeling and Methodology Work Group, and to the Architectural review Board, which he chaired for nearly a decade. Walker served on the HL7 Board of Directors from 1998-1999, and has been actively engaged in the development of Version 3. He was one of the initial authors of the Message Development Framework (MDF) and its successor, the H7 Development Framework (HDF). A sought after modeling expert, Walker has served as Modeling Facilitator for both the Patient Safety and RCRIM Work Groups, and been an active member of the Modeling and Methodology (MnM) Work Group for many years. He also serves as the co-chair to the Patient Safety Work Group and has participated in the Public Health and Emergency Response Work Group. Walker recently served another term on the newly-formed ArB and currently co-chairs the Foundation & Technology Steering Division, serving as one of that group's two representatives on the Technical Steering Committee.
Pat Van Dyke joined HL7 in 2003. An active member, she is deeply involved in the development of Electronic Health Record (EHR) standards. Van Dyke currently serves as a co-chair for the Electronic Records (EHR) Work Group and is the group's primary organizer. She coordinates and leads all weekly conference calls, face-to-face meetings, ballot submissions, and with the ArB, facilitates the process of tying the HL7 Electronic Health Record System Functional Model (EHR-S FM) to the SAIF. Van Dyke also co-leads the development of the dental functional profile for the Electronic Health Record System Functional Model (EHR-S FM).
Founded in 1987, Health Level Seven International is the global authority for healthcare Information interoperability and standards with affiliates established in more than 30 countries. HL7 is a non-profit, ANSI accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7's more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare. HL7 collaborates with other standards developers and provider, payer, philanthropic and government agencies at the highest levels to ensure the development of comprehensive and reliable standards and successful interoperability efforts.
HL7's endeavors are sponsored, in part, by the support of its benefactors: Abbott; Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Epic Systems Corporation; European Medicines Agency; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technology; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis Pharmaceuticals Corporation; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; Quest Diagnostics Inc.; Siemens Healthcare; St. Jude Medical; Thomson Reuters; the U.S. Department of Defense, Military Health System; and the U.S. Department of Veterans Affairs.
Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Finland, Germany, Greece, Hong Kong, India, Italy, Japan, Korea, The Netherlands, New Zealand, Norway, Romania, Russia, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, and Uruguay.